Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Thalidomide for systemic capillary leak syndrome.

Staak JO, Glossmann JP, Esser JM, Diehl V, Mietz H, Josting A.

Am J Med. 2003 Sep;115(4):332-4. No abstract available.

PMID:
12967704
2.

Idiopathic systemic capillary leak syndrome: novel therapy for acute attacks.

Dowden AM, Rullo OJ, Aziz N, Fasano MB, Chatila T, Ballas ZK.

J Allergy Clin Immunol. 2009 Nov;124(5):1111-3. doi: 10.1016/j.jaci.2009.06.043. No abstract available.

PMID:
19703708
3.

Systemic capillary leak syndrome associated with compartment syndrome.

Matsumura M, Kakuchi Y, Hamano R, Kitajima S, Ueda A, Kawano M, Yamagishi M.

Intern Med. 2007;46(18):1585-7.

4.

[Systemic capillary leak syndrome causes a compartment syndrome of both lower legs and a forearm. A case report with a review of the literature].

Balcarek P, Frosch KH, Quintel M, Stürmer KM.

Unfallchirurg. 2005 Sep;108(9):770, 772-5. Review. German.

PMID:
15778826
5.

High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome.

Lambert M, Launay D, Hachulla E, Morell-Dubois S, Soland V, Queyrel V, Fourrier F, Hatron PY.

Crit Care Med. 2008 Jul;36(7):2184-7. doi: 10.1097/CCM.0b013e31817d7c71.

PMID:
18552679
6.

Systemic capillary leak syndrome associated with rhabdomyolysis and compartment syndrome.

Prieto Valderrey F, Burillo Putze G, Martinez Azario J, Santana Ramos M.

Am J Emerg Med. 1999 Nov;17(7):743-4. No abstract available.

PMID:
10597109
7.

Four-limb compartment syndrome associated with the systemic capillary leak syndrome.

Simon DA, Taylor TL, Bayley G, Lalonde KA.

J Bone Joint Surg Br. 2010 Dec;92(12):1700-2. doi: 10.1302/0301-620X.92B12.25225.

PMID:
21119178
8.

Two cases of systemic capillary leak syndrome that were treated with pentastarch.

Lee YS, Kim SY, Kwon CW, Song HG, Lee YK, Kim HJ, Zang DY.

Korean J Intern Med. 2007 Jun;22(2):130-2.

9.

Thalidomide.

Radomsky CL, Levine N.

Dermatol Clin. 2001 Jan;19(1):87-103. Review.

PMID:
11155589
10.

Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia.

Shannon E, Noveck R, Sandoval F, Kamath B, Kearney M.

Transl Res. 2007 Nov;150(5):275-80.

PMID:
17964516
11.

[Systemic capillary leak syndrome associated with lymphoproliferative disease].

Puig Ponsico G, Cortada P, Celma A, Arderiu A.

Med Clin (Barc). 2002 Oct 26;119(14):558. Spanish. No abstract available.

PMID:
12421530
12.

Systemic capillary leak syndrome or Clarkson's disease: a case report.

De Martino M, Sasso L, Pirozzi F, Bonaduce D.

Intern Emerg Med. 2009 Aug;4(4):357-8. doi: 10.1007/s11739-009-0257-0. No abstract available.

PMID:
19526356
13.

Systemic capillary leak syndrome resulting in compartment syndrome and the requirement for a surgical airway.

Perry J, Balasubramanian S, Imray C.

Anaesthesia. 2009 Jun;64(6):679-82. doi: 10.1111/j.1365-2044.2009.05891.x.

14.

Systemic capillary leak syndrome: where does the fluid go?

Morton SJ, Powell RJ, Balsitis M.

Postgrad Med J. 1998 Jul;74(873):447. No abstract available.

15.

Anterior tibial compartment syndrome secondary to systemic capillary leak syndrome.

Madrenas J, García-Bragado F, Fernandez JM.

J Neurol Neurosurg Psychiatry. 1987 Jul;50(7):943-4. No abstract available.

16.

[Use of intravenous immunoglobulins in a patient with systemic capillary leak syndrome].

del Olmo Revuelto MA, Abajo del Álamo C, Santos Pérez MI.

Med Clin (Barc). 2014 Apr 22;142(8):377-8. doi: 10.1016/j.medcli.2013.06.021. Spanish. No abstract available.

PMID:
24018246
17.

[Thalidomide and thrombosis: three observations].

Pouaha J, Martin S, Trechot P, Truchetet F, Barbaud A, Schmutz JL.

Presse Med. 2001 Jun 9;30(20):1008-9. French. No abstract available.

PMID:
11433688
18.

Thalidomide in the treatment of recalcitrant Sweet's syndrome associated with myelodysplasia.

Browning CE, Dixon JE, Malone JC, Callen JP.

J Am Acad Dermatol. 2005 Aug;53(2 Suppl 1):S135-8.

PMID:
16021163
19.

Thalidomide in multiple myeloma--clinical trials and aspects of drug metabolism and toxicity.

Breitkreutz I, Anderson KC.

Expert Opin Drug Metab Toxicol. 2008 Jul;4(7):973-85. doi: 10.1517/17425255.4.7.973 . Review.

PMID:
18624684
20.

The pharmacokinetics of low-dose thalidomide in Japanese patients with refractory multiple myeloma.

Kamikawa R, Ikawa K, Morikawa N, Asaoku H, Iwato K, Sasaki A.

Biol Pharm Bull. 2006 Nov;29(11):2331-4.

Items per page

Supplemental Content

Support Center